Rankings / Results reporting
Results reporting
Industry sponsors ranked by how many of their completed trials have results posted on ClinicalTrials.gov. Sponsors with fewer completed trials than the qualifying floor are not ranked.
Last revised
Ranking
| Rank | Sponsor | Rate | Completed | With results |
|---|---|---|---|---|
| 1 | GlaxoSmithKline | 58.8% | 68 | 40 |
| 2 | Abbott Medical Devices | 55.0% | 20 | 11 |
| 3 | Merck Sharp & Dohme LLC | 46.5% | 155 | 72 |
| 4 | Hoffmann-La Roche | 46.1% | 89 | 41 |
| 5 | Alcon Research | 45.8% | 24 | 11 |
| 6 | BeiGene | 45.5% | 22 | 10 |
| 7 | Janssen Research & Development, LLC | 42.9% | 49 | 21 |
| 8 | Boston Scientific Corporation | 40.0% | 25 | 10 |
| 9 | UCB Biopharma SRL | 40.0% | 25 | 10 |
| 10 | HALEON | 38.1% | 21 | 8 |
| 11 | Incyte Corporation | 37.5% | 32 | 12 |
| 12 | Celgene | 35.0% | 20 | 7 |
| 13 | Novartis Pharmaceuticals | 33.3% | 147 | 49 |
| 14 | Amgen | 32.7% | 49 | 16 |
| 15 | Takeda | 32.3% | 65 | 21 |
| 16 | Eli Lilly and Company | 31.6% | 114 | 36 |
| 17 | Bristol-Myers Squibb | 31.0% | 100 | 31 |
| 18 | ModernaTX, Inc. | 30.8% | 26 | 8 |
| 19 | Pfizer | 28.4% | 155 | 44 |
| 20 | Boehringer Ingelheim | 27.2% | 103 | 28 |